Literature DB >> 18508528

Regulation of neurite outgrowth by G(i/o) signaling pathways.

Kenneth D Bromberg1, Ravi Iyengar, John Cijiang He.   

Abstract

Neurogenesis is a long and winding journey. A neural progenitor cell migrates long distances, differentiates by forming a single axon and multiple dendrites, undergoes maturation, and ultimately survives. The initial formation of neurites during neuronal differentiation, commonly referred to as "neurite outgrowth," can be induced by a large repertoire of signals that stimulate an array of receptors and downstream signaling pathways. The G(i/o) family of heterotrimeric G-proteins are abundantly expressed in the brain and enriched at neuronal growth cones. Recent evidence has uncovered several G(i/o)-coupled receptors that induce neurite outgrowth and has begun to elucidate the underlying molecular mechanisms. Emerging data suggests that signals from several G(i/o)-coupled receptors converge at the transcription factor STAT3 to regulate neurite outgrowth and at Rac1 and Cdc42 to regulate cytoskeletal reorganization. Physiologically, signaling through G(i/o)-coupled cannabinoid receptors is critical for pro percentral nervous system development. As the mechanisms by which G(i/o)-coupled receptors regulate neurite outgrowth are clarified, it is becoming evident that modulating signals from G(i/o) and their receptors has great potential for the treatment of neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18508528      PMCID: PMC3068557          DOI: 10.2741/3022

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  152 in total

1.  Cannabinoid receptor-induced neurite outgrowth is mediated by Rap1 activation through G(alpha)o/i-triggered proteasomal degradation of Rap1GAPII.

Authors:  J Dedrick Jordan; John Cijiang He; Narat J Eungdamrong; Ivone Gomes; Wasif Ali; Tracy Nguyen; Trever G Bivona; Mark R Philips; Lakshmi A Devi; Ravi Iyengar
Journal:  J Biol Chem       Date:  2005-01-18       Impact factor: 5.157

2.  Molecular mechanisms involved in the adenosine A and A receptor-induced neuronal differentiation in neuroblastoma cells and striatal primary cultures.

Authors:  Meritxell Canals; Ester Angulo; Vicent Casadó; Enric I Canela; Josefa Mallol; Francesc Viñals; William Staines; Barbro Tinner; Joelle Hillion; Luigi Agnati; Kjell Fuxe; Sergi Ferré; Carmen Lluis; Rafael Franco
Journal:  J Neurochem       Date:  2005-01       Impact factor: 5.372

3.  Increased nociceptive response in mice lacking the adenosine A1 receptor.

Authors:  Wei-Ping Wu; Jing-Xia Hao; Linda Halldner; Cecilia Lövdahl; Gary E DeLander; Zsuzsanna Wiesenfeld-Hallin; Bertil B Fredholm; Xiao-Jun Xu
Journal:  Pain       Date:  2005-02       Impact factor: 6.961

4.  Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.

Authors:  Belén G Ramírez; Cristina Blázquez; Teresa Gómez del Pulgar; Manuel Guzmán; María L de Ceballos
Journal:  J Neurosci       Date:  2005-02-23       Impact factor: 6.167

5.  Seizure suppression and lack of adenosine A1 receptor desensitization after focal long-term delivery of adenosine by encapsulated myoblasts.

Authors:  Martin Güttinger; Vivianne Padrun; William F Pralong; Detlev Boison
Journal:  Exp Neurol       Date:  2005-05       Impact factor: 5.330

6.  Transient receptor potential vanilloid subtype 1 mediates cell death of mesencephalic dopaminergic neurons in vivo and in vitro.

Authors:  Sang R Kim; Da Y Lee; Eun S Chung; Uh T Oh; Seung U Kim; Byung K Jin
Journal:  J Neurosci       Date:  2005-01-19       Impact factor: 6.167

7.  Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease.

Authors:  Isabel Lastres-Becker; Francisco Molina-Holgado; José A Ramos; Raphael Mechoulam; Javier Fernández-Ruiz
Journal:  Neurobiol Dis       Date:  2005 Jun-Jul       Impact factor: 5.996

8.  Functional characterization of Galphao signaling through G protein-regulated inducer of neurite outgrowth 1.

Authors:  Hiroko Nakata; Tohru Kozasa
Journal:  Mol Pharmacol       Date:  2004-12-07       Impact factor: 4.436

9.  Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis.

Authors:  Leyre Mestre; Fernando Correa; Angel Arévalo-Martín; Eduardo Molina-Holgado; Marta Valenti; Giorgio Ortar; Vincenzo Di Marzo; Carmen Guaza
Journal:  J Neurochem       Date:  2005-03       Impact factor: 5.372

Review 10.  Signalling from adenosine receptors to mitogen-activated protein kinases.

Authors:  Gunnar Schulte; Bertil B Fredholm
Journal:  Cell Signal       Date:  2003-09       Impact factor: 4.315

View more
  20 in total

Review 1.  Maternal immune activation and autism spectrum disorder: interleukin-6 signaling as a key mechanistic pathway.

Authors:  E Carla Parker-Athill; Jun Tan
Journal:  Neurosignals       Date:  2010-10-02

2.  Diacylglycerol lipase-alpha and -beta control neurite outgrowth in neuro-2a cells through distinct molecular mechanisms.

Authors:  Kwang-Mook Jung; Giuseppe Astarita; Dean Thongkham; Daniele Piomelli
Journal:  Mol Pharmacol       Date:  2011-04-14       Impact factor: 4.436

Review 3.  RHO GTPase signaling for axon extension: is prenylation important?

Authors:  Filsy Samuel; DiAnna L Hynds
Journal:  Mol Neurobiol       Date:  2010-09-28       Impact factor: 5.590

Review 4.  Role of APP Interactions with Heterotrimeric G Proteins: Physiological Functions and Pathological Consequences.

Authors:  Philip F Copenhaver; Donat Kögel
Journal:  Front Mol Neurosci       Date:  2017-01-31       Impact factor: 5.639

5.  Drosophila GoLoco-protein Pins is a target of Galpha(o)-mediated G protein-coupled receptor signaling.

Authors:  Damir Kopein; Vladimir L Katanaev
Journal:  Mol Biol Cell       Date:  2009-07-01       Impact factor: 4.138

Review 6.  Subcellular optogenetics - controlling signaling and single-cell behavior.

Authors:  W K Ajith Karunarathne; Patrick R O'Neill; Narasimhan Gautam
Journal:  J Cell Sci       Date:  2014-11-28       Impact factor: 5.285

7.  Phosphodiesterase Inhibitors Revert Axonal Dystrophy in Friedreich's Ataxia Mouse Model.

Authors:  Belén Mollá; Diana C Muñoz-Lasso; Pablo Calap; Angel Fernandez-Vilata; María de la Iglesia-Vaya; Federico V Pallardó; Maria Dolores Moltó; Francesc Palau; Pilar Gonzalez-Cabo
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

8.  Axon targeting of the alpha 7 nicotinic receptor in developing hippocampal neurons by Gprin1 regulates growth.

Authors:  Jacob C Nordman; Wiktor S Phillips; Nathan Kodama; Sarah G Clark; Christopher A Del Negro; Nadine Kabbani
Journal:  J Neurochem       Date:  2014-01-10       Impact factor: 5.372

Review 9.  CB1 and CB2 Receptor Pharmacology.

Authors:  Allyn C Howlett; Mary E Abood
Journal:  Adv Pharmacol       Date:  2017-06-12

10.  Amyloid precursor proteins interact with the heterotrimeric G protein Go in the control of neuronal migration.

Authors:  Jenna M Ramaker; Tracy L Swanson; Philip F Copenhaver
Journal:  J Neurosci       Date:  2013-06-12       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.